Amaurosis fugax: Difference between revisions

Jump to navigation Jump to search
Charmaine Patel (talk | contribs)
Charmaine Patel (talk | contribs)
Line 16: Line 16:


{{Editor join}}
{{Editor join}}
==Symptoms==
The experience of amaurosis fugax is classically described as a transient monocular vision loss that appears as a "[[curtain]] coming down vertically into the [[visual field|field of vision]] in one eye;" however, this altitudinal visual loss is relatively uncommon.  In one study, only 23.8 percent of patients with transient monocular vision loss experienced the classic "curtain" or "shade" descending over their vision.<ref name="noauthor">"Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis." ''N Engl J Med.'' 1991 August 15;325(7):445-53. PMID 1852179.</ref>  Other descriptions of this experience include a monocular blindness, dimming, fogging, or blurring.<ref name="Lord">Lord RS. "Transient monocular blindness." ''Aust N Z J Ophthalmol.'' 1990 Aug;18(3):299-305. PMID 2261177.</ref>  Total or sectorial [[vision loss]] typically lasts only a few seconds, but may last minutes or even hours.  Duration depends on the etiology of the vision loss.  Obscured vision due to papilledema may last only seconds, while a severely atherosclerotic carotid artery may be associated with a duration of one to ten minutes.<ref name="Donders">Donders RC. "Clinical features of transient monocular blindness and the likelihood of atherosclerotic lesions of the internal carotid artery." ''J Neurol Neurosurg Psychiatry.'' 2001 Aug;71(2):247-9. PMID 11459904.</ref>  Certainly, additional symptoms may be present with the amaurosis fugax, and those findings will depend on the etiology of the transient monocular vision loss.


==Diagnostic Evaluation==
==Diagnostic Evaluation==

Revision as of 14:55, 26 November 2012

Amaurosis fugax
The arteries of the choroid and iris. The greater part of the sclera has been removed.
ICD-10 G45.3
ICD-9 362.34
DiseasesDB 501
MedlinePlus 000784
MeSH D020757

Amaurosis fugax Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Amaurosis fugax from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Diagnostic Evaluation

Physical Examination

Laboratory Findings

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Amaurosis fugax On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Amaurosis fugax

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Amaurosis fugax

CDC on Amaurosis fugax

Amaurosis fugax in the news

Blogs on Amaurosis fugax

Directions to Hospitals Treating Amaurosis fugax

Risk calculators and risk factors for Amaurosis fugax

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Template:Editor join

Diagnostic Evaluation

Despite the temporary nature of the vision loss, those experiencing amaurosis fugax are usually advised to consult a physician immediately as it is a symptom that usually heralds serious vascular events, including stroke.[1][2] Restated, “because of the brief interval between the transient event and a stroke or blindness from temporal arteritis, the workup for transient monocular blindness should be undertaken without delay.” If the patient has no history of giant cell arteritis, the probability of vision preservation is high; however, the chance of a stroke reaches that for a hemispheric TIA. Therefore, investigation of cardiac disease is justified.[3]

A diagnostic evaluation should begin with the patient's history, followed by a physical exam, with particular importance being paid to the ophthalmic examination with regards to signs of ocular ischemia. When investigating amaurosis fugax, an ophthalmologic consult is absolutely warranted if available. Several concomitant laboratory tests should also be ordered to investigate some of the more common, systemic causes listed above, including a complete blood count, erythrocyte sedimentation rate, lipid panel, and blood glucose level. If a particular etiology is suspected based on the history and physical, additional relevant labs should be ordered.[3]

If laboratory tests are abnormal, a systemic disease process is likely, and, if the ophthalmologic examinaton is abnormal, ocular disease is likely. However, in the event that both of these routes of investigation yield normal findings, or an inadequate explanation, noninvasive duplex ultrasound studies are recommended to identify carotid artery disease. Most episodes of amaurosis fugax are the result of stenosis of the ipsilateral carotid artery.[4] With that being the case, researchers investigated how best to evaluate these episodes of vision loss, and concluded that for patients ranging from 36-74 years old, "...carotid artery duplex scanning should be performed...as this investigation is more likely to provide useful information than an extensive cardiac screening (ECG, Holler 24-hour monitoring and precordial echocardiography)."[4] Additionally, concomitant head CT or MRI imaging is also recommended to investigate the presence of a “clinically silent cerebral embolism.”[3]

If the results of the ultrasound and intracranial imaging are normal, “renewed diagnostic efforts may be made,” during which fluorescein angiography is an appropriate consideration. However, carotid angiography is not advisable in the presence of a normal ultrasound and CT.[5]

Differential Diagnosis of Amaurosis fugax

Cardiovascular No underlying causes
Chemical / poisoning No underlying causes
Dermatologic No underlying causes
Drug Side Effect No underlying causes
Ear Nose Throat No underlying causes
Endocrine No underlying causes
Environmental No underlying causes
Gastroenterologic No underlying causes
Genetic No underlying causes
Hematologic No underlying causes
Iatrogenic No underlying causes
Infectious Disease No underlying causes
Musculoskeletal / Ortho No underlying causes
Neurologic No underlying causes
Nutritional / Metabolic No underlying causes
Oncologic No underlying causes
Opthalmologic No underlying causes
Overdose / Toxicity No underlying causes
Psychiatric No underlying causes
Pulmonary No underlying causes
Renal / Electrolyte No underlying causes
Rheum / Immune / Allergy No underlying causes
Trauma No underlying causes
Miscellaneous No underlying causes

Treatment

If the diagnostic workup reveals a systemic disease process, directed therapies to treat that underlying etiology should be initiated. If the amaurosis fugax is caused by an atherosclerotic lesion, aspirin is indicated, and a carotid endarterectomy if the stenosis is surgically accessible. Generally, if the carotid artery is still patent, the greater the stenosis, the greater the indication for endarterectomy. "Amaurosis fugax appears to be a particularly favorable indication for carotid endarterectomy. Left untreated, this event carries a high risk of stroke; after carotid endarterectomy, which has a low operative risk, there is a very low postoperative stroke rate."[6] If the full diagnostic workup is completely normal, patient observation is recommended.[3]

Related Chapters

References

  1. Benavente, Eliasziw, Steifler, Fox, et al. "Prognosis after transient monocular blindness associated with carotid-artery stenosis." N Engl J Med. 2001;345(15):1084-1090.
  2. Rothwell, Warlow. "Timing of TIA's preceding stroke: time window for prevention is very short." Neurology. 2005;64:817.
  3. 3.0 3.1 3.2 3.3
  4. 4.0 4.1 Smit, Ronald; G. Seerp Baarsma and Peter J. Koudstaal "The source of embolism in amaurosis fugax and retinal artery occlusion." International Ophthalmology. 1994 March;18(2):83-86. ISSN 0165-5701.
  5. Walsh J, Markowitz I, Kerstein MD. "Carotid endarterectomy for amaurosis fugax without angiography." Am J Surg. 1986 Aug;152(2):172-4. PMID 3526933.
  6. Bernstein EF, Dilley RB. "Late results after carotid endarterectomy for amaurosis fugax." J Vasc Surg. 1987 Oct;6(4):333-40. PMID 3656582.


Template:Diseases of the nervous system de:Retinaler Arterienverschluss

Template:WikiDoc Sources